Predicting the Clinical Response to Omalizumab With Anti-Immunoglobulin E (IgE) Ab Response or Syk Expression in Basophils
Clinical trial NCT02023151 · COMPLETED
Trial details
- NCT number
- NCT02023151
- Sponsor
- Johns Hopkins University
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2013-02-01
- Primary completion
- 2016-06-01
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.